Nicholas Donoghoe
Fortune : 19 M $ au 31/07/2026
Fortune : 19 M $ au 31/07/2026
Nicholas J.
Donoghoe is currently Executive VP, Chief Business & Strategy Officer at AbbVie, Inc., a position held since 2019.
Formerly, Dr. Donoghoe was a Partner at McKinsey & Co., Inc. Dr. Donoghoe earned a doctorate from The Johns Hopkins University School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ABBVIE, INC. 0 % | 14/08/2026 | 74 430 ( 0 % ) | 19 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/01/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national